Deshpande Milind 4
4 · Spero Therapeutics, Inc. · Filed Aug 18, 2021
Insider Transaction Report
Form 4
Deshpande Milind
Director
Transactions
- Award
Stock Option (right to buy)
2021-08-17+7,500→ 7,500 totalExercise: $13.69Exp: 2031-08-17→ Common Stock (7,500 underlying)
Footnotes (1)
- [F1]The shares underlying this option will vest and become exercisable in full on August 17, 2022 subject to the Reporting Person's continued service as a director through the vesting date.